Yonehiro Grant

Chief Operating OfficerBolt Biotherapeutics, Inc. (BOLT) · full profile →Form 4 · filed Dec 16, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
24
0 non-derivative · 24 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 12, 2025Grant(A)8K8K
Dec 12, 2025Disposed to issuer(D)12K0
Dec 12, 2025Grant(A)17K17K
Dec 12, 2025Disposed to issuer(D)17K0
Dec 12, 2025Grant(A)3K3K
Dec 12, 2025Disposed to issuer(D)3K0
Dec 12, 2025Grant(A)660660
Dec 12, 2025Disposed to issuer(D)6600
Dec 12, 2025Grant(A)822822
Dec 12, 2025Disposed to issuer(D)8220
Dec 12, 2025Grant(A)2K2K
Dec 12, 2025Disposed to issuer(D)2K0
Dec 12, 2025Grant(A)5K5K
Dec 12, 2025Disposed to issuer(D)5K0
Dec 12, 2025Grant(A)2K2K
Dec 12, 2025Disposed to issuer(D)2K0
Dec 12, 2025Grant(A)5K5K
Dec 12, 2025Disposed to issuer(D)5K0
Dec 12, 2025Grant(A)9K9K
Dec 12, 2025Disposed to issuer(D)9K0
Dec 12, 2025Grant(A)11K11K
Dec 12, 2025Disposed to issuer(D)11K0
Dec 12, 2025Grant(A)12K12K
Dec 12, 2025Disposed to issuer(D)8K0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-321148) within minutes of acceptance. Every field above traces to the original document. Verify it directly: